🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
Durvalumab and Tremelimumab in combination with first-line chemotherapy in ...
Status
Completed
Location
Research Site
Start Date
2016-04-28
Trial ID
NCT02658214
Treatments Being Tested
This open labelled first in human dose phase 1/2a study is designed to eval...
Status
Completed
Location
Charité Research Organisation, Campus Benjamin Franklin
Start Date
2018-04-04
Trial ID
NCT03548467
Treatments Being Tested
The purpose of this study is to determine new multiscale signatures for the...
Status
Unknown
Location
Heinrich-Heine Universitaet Dusseldorf, Dept. of Othorinolaryngology, HHU
Start Date
2016-04
Trial ID
NCT02832102
Treatments Being Tested
The main purpose of this study is to compare nivolumab and ipilimumab with ...
Status
Completed
Location
Local Institution - 0134
Start Date
2016-10-05
Trial ID
NCT02741570
This is a single-center cross-sectional imaging and correlative biomarker s...
Status
Completed
Location
Stanford Hospital and Clinics
Start Date
2017-05-01
Trial ID
NCT03129061
This is a Phase 2, multicenter, open-label, 2-cohort (Locoregionally Advanc...
Status
Withdrawn
Location
University of California San Diego, UCSD
Start Date
2024-01-30
Trial ID
NCT05743270
Treatments Being Tested
Primary Objective for Phase I 1. To determine the maximally tolerated dose...
Status
Terminated
Location
Johns Hopkins Sidney Kimmel Comprehensive Cancer Center
Start Date
2009-07
Trial ID
NCT00882583
Treatments Being Tested
Phase 1: To determine the maximally tolerated dose (MTD) or recommended dos...
Status
Completed
Location
University of Alabama at Birmingham
Start Date
2010-09
Trial ID
NCT01204099
This is a randomized, open-label, multi-center, 3-arm, global Phase III stu...
Status
Completed
Location
Research Site
Start Date
2015-10-15
Trial ID
NCT02551159
Treatments Being Tested
The primary objective of the phase II trial is to determine the efficacy an...
Status
Completed
Location
CHU d'Amiens
Start Date
2019-05-16
Trial ID
NCT03723967
Treatments Being Tested